23.9 C
New York
Thursday, June 18, 2026

Tag: agent

16 PRIME FREEHOLD GROUND FLOOR RETAIL & F&B UNITS AT CROWN CENTRE FOR SALE VIA EXPRESSION OF INTEREST

SINGAPORE, Aug. 14, 2025 /PRNewswire/ -- Brilliance Capital is pleased to announce the launch of a rare investment opportunity in the heart of Bukit...

TENSOR UNVEILS WORLD’S FIRST PERSONAL AUTONOMOUS VEHICLE FOR PRIVATE OWNERSHIP–REDEFINING THE FUTURE WHERE YOU OWN YOUR AUTONOMY

Tensor is the only fully autonomous L4 Robocar that you can own. SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ -- Tensor, a leading agentic...

Vertical AI acquires equity stake in Levangie Labs to supercharge platform capabilities

WILLEMSTAD, Curaçao, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Vertical AI, is a leading AI no-code customization company behind Vertical Studio, Stream and Cloud, announced it has acquired an equity stake in Levangie Laboratories (LLABS), an advanced AI research company developing groundbreaking cognitive agent technology.

AI and the Empathy Gap: Finding the Balance between AI and Human First Customer Experience

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- While brands are celebrating AI-driven efficiency gains in customer experience (CX), a significant gap exists between their internal benefits and the often underwhelming service that consumers are actually experiencing. According to Verizon’s CX Annual Insights report, the future of CX isn't just about implementing AI, but about strategically integrating it to amplify human connections and address core customer frustrations.

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

MindHYVE.ai Partners with ICS Pakistan and NEI Pakistan to Revolutionize Nursing Education with AI-Powered ArthurAI

ISLAMABAD, Aug. 12, 2025 /PRNewswire/ --In a pioneering step towards elevating nursing education in Pakistan, MindHYVE.ai has signed strategic Memorandum of Understanding (MoU) with...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Highwoods Recasts Term Loan

RALEIGH, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has executed a recast of a $200 million unsecured bank term loan by extending the maturity date from May 2026 to January 2029. The term can be extended for two additional years at our option assuming no defaults have occurred.

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with Janus Henderson Investors, a global asset management firm, for the purchase and sale of 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

Advanced Reactor Pilot Program launched by DOE to expedite authorization and commercialization of advanced nuclear reactor designs

izmo Ltd. unveils The Automotive AI Factory

Powering the Future of Intelligent Automotive Solutions BANGALORE, India, Aug. 12, 2025 /PRNewswire/ -- izmo Ltd., a global leader in automotive digital retail solutions, today announced...

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it has closed the first tranche of its previously announced private placement offering (the “Offering”). The first tranche of the Offering consisted of the issuance of 2,900,000 units of the Company (each, a “Unit”), at a price of $0.021 per Unit, for total gross proceeds to Revive of $60,900. Furthermore, the Company announces that it has settled an amount of $67,400 owing pursuant to an arm’s length note through the issuance of 3,209,523 Units, at a price of $0.021 per Unit, being the same issue price and security offered pursuant to the Offering.

ATHA ENERGY ANNOUNCES “BEST EFFORTS” PRIVATE PLACEMENT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Aug. 11, 2025 /CNW/ - ATHA Energy Corp....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAgent